Sebastian Birndt (S Birndt)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Ejection Fraction

Top Venues

Journal of cancer research and clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Johanna Knauft, Thomas Schenk, Thomas Ernst, Ulf Schnetzke, Andreas Hochhaus, Paul La Rosée, Sebastian Birndt
Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis. Leukemia 38 (2) (2024)
Johanna Knauft, Thomas Schenk, Thomas Ernst, Ulf Schnetzke, Andreas Hochhaus, Paul La Rosée, Sebastian Birndt
Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis. Leukemia 38 (2) (2024)
Johanna Knauft, Thomas Schenk, Thomas Ernst, Ulf Schnetzke, Andreas Hochhaus, Paul La Rosée, Sebastian Birndt
Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis. Leukemia 38 (2) (2024)
Johanna Knauft, Thomas Schenk, Thomas Ernst, Ulf Schnetzke, Andreas Hochhaus, Paul La Rosée, Sebastian Birndt
Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis. Leukemia 38 (2) (2024)
Johanna Knauft, Thomas Schenk, Thomas Ernst, Ulf Schnetzke, Andreas Hochhaus, Paul La Rosée, Sebastian Birndt
Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis. Leukemia (2024)
Johanna Knauft, Thomas Schenk, Thomas Ernst, Ulf Schnetzke, Andreas Hochhaus, Paul La Rosée, Sebastian Birndt
Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis. Leukemia 38 (2) (2024)
Johanna Knauft, Thomas Schenk, Thomas Ernst, Ulf Schnetzke, Andreas Hochhaus, Paul La Rosée, Sebastian Birndt
Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis. Leukemia 38 (2) (2024)
J Hammersen, Sebastian Birndt, K Döhner, Philipp Alexander Reuken, A Stallmach, P Sauerbrey, F La Rosée, M Pfirrmann, C Fabisch, M Weiss, K Träger, H Bremer, S Russo, Gerald Illerhaus, D Drömann, S Schneider, Paul La Rosée, Andreas Hochhaus
The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 triggered hyperinflammation: the RuxCoFlam trial. Leukemia (2023)
F La Rosée, H C Bremer, I Gehrke, A Kehr, A Hochhaus, Sebastian Birndt, M Fellhauer, M Henkes, B Kumle, S G Russo, Paul La Rosée
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation. Leukemia 34 (7) (2020)
Sebastian Birndt, Thomas Schenk, Babett Heinevetter, Frank M Brunkhorst, Georg Maschmeyer, Frank Rothmann, Thomas Weber, Markus Müller, Jens Panse, Olaf Penack, Roland Schroers, Jan Braess, Norbert Frickhofen, Stephan Ehl, Gritta Janka, Kai Lehmberg, Mathias W Pletz, Andreas Hochhaus, Thomas Ernst, Paul La Rosée
Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry. Journal of cancer research and clinical oncology 146 (4) (2020)